Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers. Search by keywords: Stay Informed Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes. Newsletter Sign Up Find a Clinical Trial Refer a Patient 232 Clinical Updates found Clinical Update Axillary MRI Is No Better than a Clinical Exam Alone in Predicting Breast Cancer in Sentinel Nodes after Neoadjuvant Chemotherapy Tuesday, December 10, 2019 Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 disease. Clinical Update MSK Investigators Create a Highly Accurate Liquid Biopsy for Identifying Early-Stage HPV-Associated Oral and Anal Cancers Tuesday, December 10, 2019 At MSK we have developed a highly accurate, low-cost assay, for identifying early-stage oral and anal cancers associated with human papillomavirus (HPV) using liquid biopsy. Clinical Update Reducing Radiation for Select Patients with HPV-Associated Mouth and Throat Cancer Tuesday, December 10, 2019 Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions. Clinical Update Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer Monday, November 11, 2019 Improved understanding of the biology and molecular subtypes of non-small cell lung cancer (NSCLC) has led to the development of several biomarker-targeted therapies for patients with locally advanced and metastatic disease. Clinical Update What Comes First — Neoadjuvant Chemotherapy or Re-Resection for Patients with Incidental Gallbladder Cancer? Monday, November 11, 2019 At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure. Clinical Update Rise of the Mutant Clones: A Newly Recognized Risk Factor for CVD Tuesday, October 8, 2019 Up to 20 percent of people over the age of 70 have clonal hematopoiesis of indeterminate potential (CHIP), a condition that carries twice the risk of coronary heart disease and ischemic stroke, and worse outcomes after heart failure — independent of traditional cardiovascular risk factors. Clinical Update Testosterone Recovery Uncertain after Androgen Deprivation Therapy for Prostate Cancer Tuesday, October 8, 2019 Androgen deprivation therapy may depress testosterone for prolonged periods in older patients, or those who are on the treatment for more than six months, increasing the risk of associated adverse events, according to the results of our recent retrospective study. Clinical Update Immunotherapy and Efficacy of Chemo in Patients with Recurrent Ovarian Cancer Thursday, September 19, 2019 Chemotherapy after immune checkpoint inhibitors (ICIs) may improve survival rates in patients with heavily pretreated, recurrent ovarian cancer. Clinical Update Surgery for Advanced Ovarian Cancer Safe in Older Women Thursday, September 19, 2019 Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty. Clinical Update New Imaging Method Can Diagnose and Direct Treatment of Rare Pediatric Retinoblastoma Monday, August 5, 2019 Decreasing values for apparent diffusion coefficient (ADC) mapping derived from MRI may indicate the development of trilateral retinoblastoma in pediatric patients with bilateral retinoblastoma. Pagination Load More